Skip to main content
Back to companies
London, UKFounded 201826+ employeesPrivate
$20.8M raisedSeries A· last: series a (Nov 2023)· 3 rounds
Backed by(16 investors)

Mytos is building a fully-automated cell manufacturing platform for biotech, starting with the drug development industry

Founders

YC S18

Hiring Pitch

You rarely get the chance to change an entire industry. But that's the position we find ourselves in. Join us, and you’ll unleash scientists, accelerate their research and help get cures to patients sooner.

We’ve developed machines to fully automate human cell production - the most manual process in Biotech. Cells are used to discover and develop new drugs, and now they're being used to cure diseases like Parkinson’s and age-related blindness. Mytos will impact cure development across the board.

We're live in multibillion dollar biotechs on both coasts of the US, and raised $19m to expand into the market faster, and accelerate our development! Next year, neurons grown on our machines will be going into Parkinson patient brains.

We’ve assembled a world-class team to take on this challenge, with ex-Dyson engineers and Nature-published scientists working hand-in-hand. You can learn more about your potential Mytos teammates here: Team

Tech Stack

Mytos's tech stack covers a huge breadth of areas:

  • Cloud-hosted user app and infrastructure
  • AWS-based image processing pipelines
  • OS-level services running on on-prem linux computer within device
  • Firmware and electronics
  • Mechanical design
  • Optical design and image processing
  • Cell biology, including stem cells
  • Biochemistry for analytics
Skip jobs list

Open Positions at Mytos (2 Jobs)

2 open · 1 filled

Showing 2 jobs